HuGE Literature Finder
Records
1
-
20
| Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma. Virchows Archiv : an international journal of pathology 2022 Jun . Yamashita Atsushi, Suehara Yoshiyuki, Hayashi Takuo, Takagi Tatsuya, Kubota Daisuke, Sasa Keita, Hasegawa Nobuhiko, Ishijima Muneaki, Yao Takashi, Saito Tsuyos |
| Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Experimental eye research 2022 8 224 109211. Mendonça Vanessa, Pereira Sena Priscila, Evangelista Dos Santos Anna Claudia, Rodrigues Bonvicino Cibele, Ashton-Prolla Patricia, Epelman Sidnei, Ferman Sima Esther, Lapunzina Pablo, Nevado Julián, Grigorovski Nathalia, Mattosinho Clarissa, Seuànez Hector, Regla Vargas Fernan |
| The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications. Precision clinical medicine 2022 6 3 (3): 153-160. Vlachostergios Panagiotis |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas. The oncologist 2021 Mar . Huang Richard S P, Haberberger James, Harries Lukas, Severson Eric, Duncan Daniel L, Ferguson N Lynn, Hemmerich Amanda, Edgerly Claire, Murugesan Karthikeyan, Xiao Jinpeng, McEwan Deborah, Holmes Oliver, Hiemenz Matthew, Venstrom Jeffrey, Elvin Julia A, Creeden James, Lin Douglas I, Ross Jeffrey S, Ramkissoon Shakti |
| Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma. Clinical lung cancer 2021 3 22 (4): 282-291.e6. Shirasawa Masayuki, Yoshida Tatsuya, Takayanagi Daisuke, Shiraishi Kouya, Yagishita Shigehiro, Sekine Katsutoshi, Kanda Shintaro, Matsumoto Yuji, Masuda Ken, Shinno Yuki, Okuma Yusuke, Goto Yasushi, Horinouchi Hidehito, Hamada Akinobu, Kohno Takashi, Yamamoto Noboru, Watanabe Shun-Ichi, Ohe Yuichiro, Motoi Nori |
| Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. Breast cancer research and treatment 2021 6 189 (1): 187-202. Ademuyiwa Foluso O, Chen Ina, Luo Jingqin, Rimawi Mothaffar F, Hagemann Ian S, Fisk Bryan, Jeffers Gejae, Skidmore Zachary L, Basu Anamika, Richters Megan, Ma Cynthia X, Weilbaecher Katherine, Davis Jennifer, Suresh Rama, Peterson Lindsay L, Bose Ron, Bagegni Nusayba, Rigden Caron E, Frith Ashley, Rearden Timothy P, Hernandez-Aya Leonel F, Roshal Anna, Clifton Katherine, Opyrchal Mateusz, Akintola-Ogunremi Olaronke, Lee Byung Ha, Ferrando-Martinez Sara, Church Sarah E, Anurag Meenakshi, Ellis Matthew J, Gao Feng, Gillanders William, Griffith Obi L, Griffith Malac |
| Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma. Scientific reports 2020 7 10 (1): 10881. Nishimura Toshihide, Nakamura Haruhiko, Yachie Ayako, Hase Takeshi, Fujii Kiyonaga, Koizumi Hirotaka, Naruki Saeko, Takagi Masayuki, Matsuoka Yukiko, Furuya Naoki, Kato Harubumi, Saji Hisas |
| Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis. Journal of medical genetics 2020 10 59 (1): 10-17. Ding Ying, Shao Yang, Na Chenglong, Yin Jiani C, Hua Hongjin, Tao Ran, Jiang Yue, Hu Ran, He Xiao, Miao Chen, Zhu Dongqin, Zhang Zhiho |
| Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients. In vivo (Athens, Greece) 2020 11 34 (6): 3375-3385. Kim Moonsik, Chung Yeon Seung, Kim Kyoung A, Shim Hyo S |
| Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies. International journal of cancer 2019 Oct . Qian Jie, Nie Wei, Lu Jun, Zhang Lele, Zhang Yanwei, Zhang Bo, Wang Shuyuan, Hu Minjuan, Xu Jianlin, Lou Yuqing, Dong Yu, Niu Yanjie, Yan Bo, Zhong Runbo, Zhang Wei, Chu Tianqing, Zhong Hua, Han Baoh |
| Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer. European urology 2019 Jul 76 (1): 89-97. Hamid Anis A, Gray Kathryn P, Shaw Grace, MacConaill Laura E, Evan Carolyn, Bernard Brandon, Loda Massimo, Corcoran Niall M, Van Allen Eliezer M, Choudhury Atish D, Sweeney Christopher |
| Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer. European urology 2016 Aug . Longo Thomas, McGinley Kathleen F, Freedman Jennifer A, Etienne Wiguins, Wu Yuan, Sibley Alexander, Owzar Kouros, Gresham Jeremy, Moy Christopher, Szabo Stephen, Greshock Joel, Zhou Hui, Bai Yuchen, Inman Brant |
| Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 2015 Dec . Goh Gerald, Walradt Trent, Markarov Vladimir, Blom Astrid, Riaz Nadeem, Doumani Ryan, Stafstrom Krista, Moshiri Ata, Yelistratova Lola, Levinsohn Jonathan, Chan Timothy A, Nghiem Paul, Lifton Richard P, Choi Jaehy |
| Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014 May 509 (7498): 91-5. Song Yongmei, Li Lin, Ou Yunwei, Gao Zhibo, Li Enmin, Li Xiangchun, Zhang Weimin, Wang Jiaqian, Xu Liyan, Zhou Yong, Ma Xiaojuan, Liu Lingyan, Zhao Zitong, Huang Xuanlin, Fan Jing, Dong Lijia, Chen Gang, Ma Liying, Yang Jie, Chen Longyun, He Minghui, Li Miao, Zhuang Xuehan, Huang Kai, Qiu Kunlong, Yin Guangliang, Guo Guangwu, Feng Qiang, Chen Peishan, Wu Zhiyong, Wu Jianyi, Ma Ling, Zhao Jinyang, Luo Longhai, Fu Ming, Xu Bainan, Chen Bo, Li Yingrui, Tong Tong, Wang Mingrong, Liu Zhihua, Lin Dongxin, Zhang Xiuqing, Yang Huanming, Wang Jun, Zhan Qim |
| [Molecular diagnosis of retinoblastoma: molecular epidemiology and genetic counseling]. Medicina clínica 2006 Mar 126 (11): 401-5. Alonso Javier, Palacios Itziar, Gámez Angelo, Camino Isabel, Frayle Helena, Menéndez Ibis, Kontic Milica, García-Miguel Purificación, Sastre Ana, Abelairas José, Sarret Enric, Sabado Constantino, Navajas Aurora, Artigas Mercé, Indiano José M, Carbone Ana, Rosell Jordi, Pestaña Ang |
| RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC genetics 2005 6 (): 53. Valverde José R, Alonso Javier, Palacios Itziar, Pestaña Ang |
| Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p. European journal of cancer (Oxford, England : 1990) 2003 6 39 (10): 1478-85. Gonzalez-Gomez P, Bello M J, Lomas J, Arjona D, Alonso M E, Amiñoso C, Lopez-Marin I, Anselmo N P, Sarasa J L, Gutierrez M, Casartelli C, Rey J |
| CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients. Cancer genetics and cytogenetics 2003 3 142 (1): 21-4. Gonzalez-Gomez Pilar, Bello M Josefa, Arjona Dolores, Alonso M Eva, Lomas Jesus, Amiñoso Cinthia, de Campos Jose M, Sarasa Jose L, Gutierrez Manuel, Rey Juan |
| Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. Journal of neuropathology and experimental neurology 2001 8 60 (8): 808-16. Dong S M, Pang J C, Poon W S, Hu J, To K F, Chang A R, Ng H |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: